Margaret Harris, Summit Chandran, Nabonita Chakraborty, David Healy
Index: Bipolar Disord. 5(6) , 446-52, (2003)
Full Text: HTML
To review the history of 'mood-stabilizing' treatments.We have reviewed primary source data on the origin of the use of current mood-stabilizers.This historical record on the origins of the mood-stabilizers points to a more ambiguous picture as regards pharmacotherapeutic specificity to bipolar disorders than is commonly conceded.This review suggests a need for alternative formulations of the concept of a mood-stabilizer. An alternative to the currently dominant paradigm is that these agents have treatment effects, which need to be matched more precisely with patients' constitutional types in order to optimize outcomes.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Valpromide
CAS:2430-27-5 |
C8H17NO |
|
The synergistic effects of DNA-damaging drugs cisplatin and ...
2015-07-01 [Int. J. Oncol. 47 , 343-52, (2015)] |
|
Amidic modification of valproic acid reduces skeletal terato...
2004-02-01 [Birth Defects Res. B Dev. Reprod. Toxicol. 71(1) , 47-53, (2004)] |
|
Polycomb homologs are involved in teratogenicity of valproic...
2004-11-01 [Birth Defects Res. A Clin. Mol. Teratol. 70(11) , 870-9, (2004)] |
|
Mood stabilizer augmentation in apparently "unipolar" MDD: p...
2005-02-01 [J. Affect. Disord. 84(2-3) , 243-9, (2005)] |
|
Characterization of the anticonvulsant profile of valpromide...
2004-07-15 [Bioorg. Med. Chem. 12(14) , 3857-69, (2004)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
